A detailed history of Balasa Dinverno & Foltz LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 20,065 shares of BMY stock, worth $1.16 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
20,065
Previous 22,111 9.25%
Holding current value
$1.16 Million
Previous $1.7 Million 16.27%
% of portfolio
0.09%
Previous 0.11%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022

SELL
$0.13 - $76.84 $265 - $157,214
-2,046 Reduced 9.25%
20,065 $1.43 Million
Q2 2022

Aug 09, 2022

BUY
$72.62 - $79.98 $268,548 - $295,766
3,698 Added 20.08%
22,111 $1.7 Million
Q1 2022

Apr 25, 2022

BUY
$61.48 - $73.72 $125,480 - $150,462
2,041 Added 12.47%
18,413 $1.35 Million
Q4 2021

Jan 26, 2022

SELL
$53.63 - $62.52 $383,186 - $446,705
-7,145 Reduced 30.38%
16,372 $1.02 Million
Q3 2021

Oct 26, 2021

BUY
$59.17 - $69.31 $9,940 - $11,644
168 Added 0.72%
23,517 $1.39 Million
Q2 2021

Jul 23, 2021

SELL
$61.91 - $67.42 $20,058 - $21,844
-324 Reduced 1.37%
23,349 $1.56 Million
Q1 2021

Apr 29, 2021

SELL
$59.34 - $66.74 $61,535 - $69,209
-1,037 Reduced 4.2%
23,673 $1.49 Million
Q4 2020

Jan 26, 2021

BUY
$57.74 - $65.43 $53,120 - $60,195
920 Added 3.87%
24,710 $1.53 Million
Q3 2020

Nov 10, 2020

BUY
$57.43 - $63.64 $56,166 - $62,239
978 Added 4.29%
23,790 $1.43 Million
Q2 2020

Aug 07, 2020

SELL
$54.82 - $64.09 $147,575 - $172,530
-2,692 Reduced 10.56%
22,812 $1.34 Million
Q1 2020

Apr 30, 2020

BUY
$46.4 - $67.43 $43,384 - $63,047
935 Added 3.81%
25,504 $1.42 Million
Q4 2019

Jan 22, 2020

BUY
$49.21 - $64.19 $357,510 - $466,340
7,265 Added 41.98%
24,569 $1.58 Million
Q3 2019

Nov 06, 2019

SELL
$42.77 - $50.71 $16,423 - $19,472
-384 Reduced 2.17%
17,304 $877,000
Q2 2019

Aug 07, 2019

SELL
$44.62 - $49.34 $37,480 - $41,445
-840 Reduced 4.53%
17,688 $802,000
Q1 2019

May 10, 2019

SELL
$45.12 - $53.8 $42,367 - $50,518
-939 Reduced 4.82%
18,528 $884,000
Q4 2018

Feb 04, 2019

SELL
$48.76 - $63.23 $203,719 - $264,174
-4,178 Reduced 17.67%
19,467 $1.01 Million
Q3 2018

Oct 24, 2018

SELL
$55.19 - $62.25 $14,183 - $15,998
-257 Reduced 1.08%
23,645 $1.47 Million
Q2 2018

Aug 01, 2018

SELL
$50.53 - $62.98 $66,952 - $83,448
-1,325 Reduced 5.25%
23,902 $1.32 Million
Q1 2018

Apr 23, 2018

SELL
$59.92 - $68.98 $18,575 - $21,383
-310 Reduced 1.21%
25,227 $1.6 Million
Q4 2017

Feb 05, 2018

SELL
$59.94 - $65.35 $19,960 - $21,761
-333 Reduced 1.29%
25,537 $1.57 Million
Q3 2017

Oct 18, 2017

BUY
$55.23 - $63.74 $1.43 Million - $1.65 Million
25,870
25,870 $1.65 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Balasa Dinverno & Foltz LLC Portfolio

Follow Balasa Dinverno & Foltz LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.